Ye Wang1,2, Zexuan Hu3, Chutong He1,2, Ruili Wei1,2, Xinrui Pang1,2, Fangrong Liang1,2, Aaron Zhang4, Yongzhou Xu4, Shiwen Yuan1,5, and Ruimeng Yang1,2
1The second Affiliated Hospital Guangzhou, School of Medicine, South China University of Technology, Guangzhou, China, 2Department of Radiology, Guangzhou First People’s Hospital, Guangzhou, China, 3Department of Radiology, TCM-integrated Hospital of Southern Medical University, Guangzhou, China, 4Philips Healthcare, Guangzhou, China, Guangzhou, China, 5Department of Rheumatology, Guangzhou First People’s Hospital, Guangzhou, China
Synopsis
Keywords: Kidney, fMRI, split-renal function
Lupus
nephritis (LN) is one of the most severe manifestations of systemic lupus
erythematosus (SLE) that can progress to end-stage kidney disease. This study
aimed to detect the split-renal function changes in early-LN by using BOLD-MRI.
The results demonstrated the R2*, as a biomarker for tissue oxygenation, was
significantly lower in cortex and medulla in the early-LN patients compared to
the healthy volunteers. Moreover, The R2* in medulla remained a considerable
good power in predicting early-LN, suggesting it has the potential to be
employed as a noninvasive imaging biomarker for early-LN patients with SLE.
Introduction
Systemic
lupus erythematosus (SLE) is a chronic multisystem autoimmune disease, in which
80% involve renal injury, known as lupus nephritis (LN), and it is also the
most severe cause of morbidity and mortality for this disease.1 Therefore, early identification of renal
function damage in LN is of great importance. Renal hypoxia has been reported
as the main driver in pathophysiological changes underlying the progression of
LN. 2 Employing BOLD-MRI, which is a
noninvasive approach capable to detect oxygenation, our aim is to evaluate
whether BOLD-MRI could identify the early alterations of split-renal function
in LN. Methods
Nineteen
age- and sex-matched healthy volunteers (HVs) and 17 patients with early-LN
were enrolled in this study (Fig.1). All the participants were performed
BOLD-MRI scans and LN patients were also performed radionuclide renal dynamic
imaging. The clinical data including estimated
glomerular filtration rate (eGFR), creatinine
(Cr), uric acid (UA), radionuclide glomerular
filtration rate (rGFR) and split-renal function
were collected. Circle-shaped regions of interest (ROIs) were placed in the
upper, middle and inferior poles of the renal cortex and medulla respectively,
to obtain R2* values (Fig.2). To further investigate the potential of BOLD-MRI
in detecting early renal function alterations compared with the radionuclide
renal dynamic imaging, the early-LN patients were then divided into LN patients
with normal rGFR (LN-normal group) vs. LN patients with mild decreased rGFR
(LN-mild group) based on the rGFR.3Results
The
demographic and clinical characteristics of participants were presented in Table 1.
The R2* in the
cortex (p=0.015) and medulla (p<0.0001) were both significantly
lower in LN group (Fig.3A, B), suggesting higher oxygenation detected in early-LN.
Furthermore, to
observe the associations between the indices of BOLD and early-LN, logistic
regression was performed on each variable for the univariate model and
combining clinical factors for the multivariate model (Table 2), the R2*_Medulla remained a stable and
independent predictor for early-LN patients in both the univariate and
multivariate model (Univariate: OR 0.758, 95% CI 0.645-0.890, p = 0.001;
Multivariate: OR 0.765, 95% CI 0.606-0.966, p = 0.024).
The AUC (Fig.3C) of the R2*_Medulla as an
independent predictor for early-LN was 0.741 (95% CI
0.628-0.853, p<0.0001). For the multivariate model, combining the
R2*_Medulla, R2*_Cortex and UA these three factors together have shown the
stronger power in predicting early-LN, the AUC of this model was 0.916 (95% CI
0.848-0.983, p<0.0001).
In all LN
patients, only 12 patients (24 kidneys) have been detected slightly declined
rGFR by radionuclide renal dynamic imaging examination, and 5 patients (10
kidneys) were with normal rGFR. The split-renal function between these two
groups were not significantly different. However, the R2* in medulla have been
detected significantly lower both in LN-normal and LN-mild groups, compared to
the HVs group.Discussion
In this study, we found that the R2* in medulla was significantly lower in patients in any LN group (early-LN, LN-normal and LN-mild group), and this index was a significant predictor for early-LN in univariate and multivariate model. This result indicates that the R2* in medulla has the potential being an imaging biomarker for early-LN patients in SLE.
Although
glomerulonephritis is the main pathological damage of LN, recent research has
observed tubulointerstitial injury can also exacerbate renal function in LN,
and this mainly could be reflected through hypoxia.4 Our study demonstrated the R2* in the
medulla and cortex is significantly lower, suggesting higher tissue oxygenation
detected in early-LN. This is consistent with the hypothesis that the reduced
metabolism and oxygen consumption lead to disturbed tubular reabsorption
processes which caused the higher tissue oxygenation in early-LN, according to
previous studies.5 Thus,
decreased R2* would represent an imaging marker of early tubulonecrosis which
could be observed in early-LN. Furthermore, the R2* in medulla maintained a
strong association with early-LN in the univariate and multivariate model. The
AUC results showed that R2* in medulla as an independent predictor had good
predict power; when combined with the clinical factors, the multivariate model
demonstrated stronger predict power for early-LN. The findings indicate the
potential possibility of R2* as an imaging biomarker for early-LN among SLE
patients.
Besides, when dividing the early-LN
patients into LN-normal and LN-mild group based on the rGFR, only 12 patients
(24 kidneys) have been detected slightly declined rGFR and 5 patients (10
kidneys) were with normal rGFR. The split-renal function between these two
groups was not significantly different. However, the R2* in medulla have been
detected as significantly different both in LN-normal and LN-mild groups,
compared to the HVs group. The findings indicate the R2* has a higher
sensibility to detecting the renal functional changes in the early stage of LN.Conclusion
BOLD-MRI
has the capacity to detect and quantify the split-renal functional changes in
early-LN and the index-R2* could probably be an imaging biomarker for detecting
early-LN in SLE. Moreover, it demonstrated a considerable potential with higher
sensitivity than radionuclide renal dynamic imaging in detecting the
split-renal functional changes with early-LN in this study. The finding needs
to be further investigated through more extensive longitudinal study.Acknowledgements
This
study was funded by the National Natural Science Foundation of China (81971574, 82271938), the
Natural Science Foundation of Guangdong Province (2021A1515011350), the
Guangdong Basic and Applied Basic Research Foundation (2021A1515220060), the
Science and Technology Project of Guangzhou (202102010025), Guangzhou Key
Laboratory of Molecular Imaging and Clinical Translational
Medicine (202201020376).References
1. Anders HJ, Saxena R, Zhao M hui, Parodis I,
Salmon JE, Mohan C. Lupus nephritis. Nat Rev Dis Primers. 2020;6(1):7.
2. Palm F, Nordquist L. Renal
tubulointerstitial hypoxia: Cause and consequence of kidney dysfunction: Renal
tubulointerstitial hypoxia. Clinical and Experimental Pharmacology and
Physiology. 2011;38(7):474-480.
3. Blaufox MD, Aurell M, Bubeck B, et al.
Report of the Radionuclides in Nephrourology Committee on renal clearance. J
Nucl Med. 1996;37(11):1883-1890.
4. Yu F, Haas M, Glassock R, Zhao MH.
Redefining lupus nephritis: clinical implications of pathophysiologic subtypes.
Nat Rev Nephrol. 2017;13(8):483-495.
5. Diffusion weighted imaging and blood oxygen
level-dependent MR imaging of kidneys in patients with lupus nephritis -
PubMed. Accessed November 8, 2022.